ATE250421T1 - Zusammensetzung enthaltend einen extrakt aus perna canaliculus, methylsulfonylmethan und glucosamine und verwendung - Google Patents

Zusammensetzung enthaltend einen extrakt aus perna canaliculus, methylsulfonylmethan und glucosamine und verwendung

Info

Publication number
ATE250421T1
ATE250421T1 AT00960126T AT00960126T ATE250421T1 AT E250421 T1 ATE250421 T1 AT E250421T1 AT 00960126 T AT00960126 T AT 00960126T AT 00960126 T AT00960126 T AT 00960126T AT E250421 T1 ATE250421 T1 AT E250421T1
Authority
AT
Austria
Prior art keywords
methylsulfonylmethane
glucosamine
extract
composition containing
perna canaliculus
Prior art date
Application number
AT00960126T
Other languages
English (en)
Inventor
Roger V Kendall
Original Assignee
Foodscience Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Foodscience Corp filed Critical Foodscience Corp
Application granted granted Critical
Publication of ATE250421T1 publication Critical patent/ATE250421T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Dental Preparations (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00960126T 1999-07-06 2000-07-06 Zusammensetzung enthaltend einen extrakt aus perna canaliculus, methylsulfonylmethan und glucosamine und verwendung ATE250421T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14239299P 1999-07-06 1999-07-06
PCT/US2000/040298 WO2001001976A2 (en) 1999-07-06 2000-07-06 Composition comprising an extract of perna canaliculus, methylsulfonylmethane and glucosamine

Publications (1)

Publication Number Publication Date
ATE250421T1 true ATE250421T1 (de) 2003-10-15

Family

ID=22499671

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00960126T ATE250421T1 (de) 1999-07-06 2000-07-06 Zusammensetzung enthaltend einen extrakt aus perna canaliculus, methylsulfonylmethan und glucosamine und verwendung

Country Status (10)

Country Link
EP (1) EP1227826B1 (de)
AT (1) ATE250421T1 (de)
AU (1) AU771808B2 (de)
CA (1) CA2375743C (de)
DE (1) DE60005548T2 (de)
DK (1) DK1227826T3 (de)
ES (1) ES2207550T3 (de)
MX (1) MXPA02000052A (de)
PT (1) PT1227826E (de)
WO (1) WO2001001976A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070141181A1 (en) 1998-02-13 2007-06-21 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
AU2000275502A1 (en) * 2000-10-03 2002-04-15 Nutraceutics Limited A therapeutic formulation containing glucosamine, methylsulfonymethane and eventually ascorbic acid and manganese
ITBS20040068A1 (it) * 2004-05-24 2004-08-24 Gen Topics Srl Composizione cosmetica e/o farmaceutica per il trattamento della rosacea
NZ574317A (en) * 2009-01-20 2010-10-29 Bomac Research Ltd Improved animal treatment
NZ575985A (en) * 2009-03-31 2010-04-30 Bomac Research Ltd Medicament Uptake
AU2021221725A1 (en) * 2021-08-25 2023-03-16 Beyond Capital LP Improvements in and relating to compositions for alleviating the effects/symptoms of inflammation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ314867A (en) * 1997-05-21 1999-04-29 Mcfarlane Lab New Zealand Ltd Glucosamine and mussel extract compositions for use as anti-inflammatories
ZA995557B (en) * 1998-05-29 2000-04-12 Log Negentien Beleggings Pty L A chemical substance.
DE19838794A1 (de) * 1998-08-26 2000-03-09 Aristavet Veterinaerspezialita Zusammensetzung zur Behandlung von Osteoarthritis und zur nutritiven Behandlung des Gelenkknorpels
US6417227B1 (en) * 1999-04-28 2002-07-09 Cg And Associates Methods of delivery of cetyl myristoleate

Also Published As

Publication number Publication date
WO2001001976A3 (en) 2002-05-10
DE60005548D1 (de) 2003-10-30
WO2001001976A2 (en) 2001-01-11
DK1227826T3 (da) 2004-01-12
PT1227826E (pt) 2004-02-27
EP1227826B1 (de) 2003-09-24
AU771808B2 (en) 2004-04-01
EP1227826A2 (de) 2002-08-07
MXPA02000052A (es) 2003-07-21
AU7133300A (en) 2001-01-22
ES2207550T3 (es) 2004-06-01
CA2375743C (en) 2008-11-18
DE60005548T2 (de) 2004-08-05
CA2375743A1 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
CY1116464T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
EA200100872A1 (ru) Композиция валдекоксиба
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
CY1111433T1 (el) Φαρμακευτικο τυποποιημενο παρασκευασμα δεσιταβινης
CY1109242T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου
TW200612987A (en) Combination treatment for non-hematologic malignancies
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
BR0108173A (pt) Composições farmacêuticas de toxina de botulina
AU2003301190A1 (en) Administration of capsaicinoids
TW200727903A (en) Stable pharmaceutical compositions of 5, 10 methylenetetrahydrofolate
DE69710065D1 (de) Androsten-derivate
ATE332136T1 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
BR0209922A (pt) Método para tratar uma condição médica que envolve a angiogênese em um paciente, para inibir a vascularização de células endoteliais, e para tratar câncer em um mamìfero
ATE441423T1 (de) Verwendung von mastix und dessen ätherischen ílen zur verhinderung oder bekämpfung von mikrobieller infektionen
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
BRPI0606528A8 (pt) composição para uso no fabrico de medicamentos de tratamento da infertilidade masculina e uso da mesma
BRPI0413410A (pt) co-administração de um polissacarìdeo com um agente quimioterapêutico para o tratamento de cáncer
DE60005548D1 (de) Zusammensetzung enthaltend einen extrakt aus perna canaliculus, methylsulfonylmethan und glucosamine und verwendung
BR0208655A (pt) Composição farmacêuticas
DE60142065D1 (de) Aliphatisch substituierte demethoxylierte hypocrelline und deren herstellung
ATE466587T1 (de) Valeriana officinalis extrakt zur behandlung von schlafapnoe oder hypopnoe
ATE346080T1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
BRPI0414454A (pt) agentes antibacterianos
MXPA04005265A (es) Uso de derivados del acido 4-oxobutanoico para el tratamiento contra inflamacion.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1227826

Country of ref document: EP

REN Ceased due to non-payment of the annual fee